US FDA’s Project Site Selector Kicks Off With A Look At Why Cancer Trials Go Overseas

 
• By Sue Sutter

Speed, logistics and global regulatory demands are all reasons why sponsors increasingly look outside the US to enroll cancer trials, industry reps say during the inaugural event for the Oncology Center of Excellence's new initiative; OCE director Pazdur says multiregional trials can help provide patients access to important new drugs quickly in the US or worldwide.

Global map
FDA's Richard Pazdur wants cancer clinical trials to include adequate representation from the US and other regions across the globe. • Source: Shutterstock

More from Clinical Trials

More from R&D